Literature DB >> 1824797

Expression of recombinant dystrophin and its localization to the cell membrane.

C C Lee1, J A Pearlman, J S Chamberlain, C T Caskey.   

Abstract

Duchenne's muscular dystrophy (DMD) is an X-linked progressive myopathy caused by a defect in the DMD gene locus. The gene corresponding to the DMD locus produces a 14-kilobase (kb) messenger RNA that codes for a large cytoskeletal membrane protein, dystrophin. DMD and Becker's muscular dystrophy are the consequences of dystrophin mutations. The exact biological function of dystrophin remains unknown but it has been demonstrated that it is localized to the cytoplasmic face of the cell membrane and has direct interaction with several other membrane proteins. We report here the synthesis of a 14-kb full-length complementary DNA for the mouse muscle dystrophin mRNA and the expression of this cDNA in COS cells. The recombinant dystrophin is indistinguishable from mouse muscle dystrophin by western blot analysis with anti-dystrophin antibodies and was shown by an immunofluorescent technique to be localized in the cell membrane. Our successful construction of a functional full-length cDNA opens opportunities for the study of structure and function of dystrophin and provides an opportunity to initiate gene therapy studies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824797     DOI: 10.1038/349334a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  19 in total

1.  Replication of lengthened Moloney murine leukemia virus genomes is impaired at multiple stages.

Authors:  N H Shin; D Hartigan-O'Connor; J K Pfeiffer; A Telesnitsky
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 2.  Molecular biology of neurological diseases.

Authors:  W J Cumming
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

Review 3.  Recent advances in understanding muscular dystrophy.

Authors:  K M Bushby
Journal:  Arch Dis Child       Date:  1992-10       Impact factor: 3.791

Review 4.  The muscular dystrophies.

Authors:  V Dubowitz
Journal:  Postgrad Med J       Date:  1992-07       Impact factor: 2.401

5.  An intact cysteine-rich domain is required for dystrophin function.

Authors:  R D Bies; C T Caskey; R Fenwick
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

6.  Human and murine dystrophin mRNA transcripts are differentially expressed during skeletal muscle, heart, and brain development.

Authors:  R D Bies; S F Phelps; M D Cortez; R Roberts; C T Caskey; J S Chamberlain
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

7.  A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and beta-galactosidase.

Authors:  S Kochanek; P R Clemens; K Mitani; H H Chen; S Chan; C T Caskey
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

Review 8.  Prospects for gene therapy in sports medicine.

Authors:  T G Gerich; F H Fu; P D Robbins; C H Evans
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  1996       Impact factor: 4.342

9.  Specific interaction of the actin-binding domain of dystrophin with intermediate filaments containing keratin 19.

Authors:  Michele R Stone; Andrea O'Neill; Dawn Catino; Robert J Bloch
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

10.  Human dystrophin gene transfer: production and expression of a functional recombinant DNA-based gene.

Authors:  G Dickson; D R Love; K E Davies; K E Wells; T A Piper; F S Walsh
Journal:  Hum Genet       Date:  1991-11       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.